David Scadden

David Scadden

Directeur/Membre du Conseil chez EDITAS MEDICINE, INC.

Fortune : 383 049 $ au 30/04/2024

71 ans
Health Technology
Consumer Services
Health Services

Profil

David T.
Scadden
is the founder of Fate Therapeutics, Inc. (founded in 2007), the Massachusetts General Hospital Cancer Center (founded in 2003), the Harvard Stem Cell Institute (founded in 2004), and Magenta Therapeutics, Inc. (founded in 2015).
He is also the founder of Garuda Therapeutics, Inc., The General Hospital Corp., and Clear Creek Bio, Inc. Dr. Scadden's current job(s) include Chairman-Emeritus & Professor at Harvard University (since 2006), Chairman-Emeritus & Professor at Harvard Medical School, Independent Director at Agios Pharmaceuticals, Inc. (since 2017), Independent Director at Editas Medicine, Inc. (since 2019), Director at Red Oak Medicines, Inc., Director at Lifevault Bio, Director at Sonata Therapeutics, Inc., Associate Member at Massachusetts Institute of Technology, Member of the American Academy of Arts & Sciences, Member of the National Academy of Medicine (United States), Associate Member at The Broad Institute, Inc., Fellow of the American Association, and Fellow of the American College of Physicians.
Dr. Scadden's former job(s) include Director of The International Society for Stem Cell Research, Member of the National Cancer Institute's Scientific Counselors Board, and Member of the National Heart, Lung & Blood Institute's External Experts Board.
Dr. Scadden's education history includes an undergraduate degree from Bucknell University, a doctorate degree from Case Western Reserve University, and a doctorate degree from the University of Lund.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2024 12 095 ( 0,02% ) 383 049 $ 30/04/2024
02/04/2024 0 ( -.--% ) - $ 30/04/2024

Postes actifs de David Scadden

SociétésPosteDébut
AGIOS PHARMACEUTICALS, INC. Directeur/Membre du Conseil 27/05/2017
EDITAS MEDICINE, INC. Directeur/Membre du Conseil 06/02/2019
Directeur/Membre du Conseil -
American Association Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Fondateur -
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tous les postes actifs de David Scadden

Anciens postes connus de David Scadden

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de David Scadden

Formation de David Scadden

Bucknell University Undergraduate Degree
Case Western Reserve University Doctorate Degree
University of Lund Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Scadden

Relations

100 +

Relations au 1er degré

26

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
FATE THERAPEUTICS, INC.

Health Technology

AGIOS PHARMACEUTICALS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

Entreprise privées17
The International Society for Stem Cell Research

Health Services

Health Technology

National Heart, Lung & Blood Institute

Government

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Services

Miscellaneous

Health Technology

American Association

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Scadden
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT